List view / Grid view
Cannabinoids, their potential therapeutic uses and the research needed for medical cannabis were the topics of discussion at the ‘Medical cannabis: what UK doctors need to know’ event held last week.
A first-of-its-kind experimental chlamydia vaccine trial has been found to be safe and able to provoke an immune response.
A study has shown that thousands of heart attacks and deaths caused by cardiovascular disease could be prevented through the use of statins...
Severe asthma sufferers could benefit from newer targeted therapies, and could be identified through levels of periostin in their airways...
Machine learning has detected one of the commonest causes of dementia and stroke, in the most widely used form of brain scan (CT), more accurately than current methods.
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings...
A new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accurately...
The EC has approved Alofisel for the treatment of complex perianal fistulae in adult patients with nonactive/mildly active luminal Crohn’s disease...
A new class of experimental drugs reduces hot flushes in menopausal women by almost three-quarters in just three days...
Health Data Research UK is awarding £30 million funding to six sites across the UK to address challenging healthcare issues through the use of data science...
A new 3D printing technique allows researchers to replicate biological structures, which could be used for tissue regeneration and replica organs...
An immunotherapy drug can be used to cure a rare type of cancer arising from pregnancy when existing treatments have failed...
Glatiramer acetate, a drug used to treat multiple sclerosis, has been found to have an effect on drug-resistant bacteria...
7 June 2017 | By Niamh Marriott, Junior Editor
Data has shown similarity in efficacy and safety between CT-P6 (biosimilar trastuzumab candidate) and reference trastuzumab treatment in patients...
6 April 2017 | By Niamh Marriott, Junior Editor
In a trial carried out at Imperial College, researchers showed that women who suffered seven or more hot flushes a day could reduce the number by 73%...
